Search

Your search keyword '"Limdi, Nita A."' showing total 570 results

Search Constraints

Start Over You searched for: Author "Limdi, Nita A." Remove constraint Author: "Limdi, Nita A."
570 results on '"Limdi, Nita A."'

Search Results

2. Advancing genomics to improve health equity.

3. A methylation risk score for chronic kidney disease: a HyperGEN study

5. Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations

6. Meta-analysis of genome-wide association studies of stable warfarin dose in patients of African ancestry

7. Returning integrated genomic risk and clinical recommendations: The eMERGE study

8. Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

10. Education and electronic medical records and genomics network, challenges, and lessons learned from a large-scale clinical trial using polygenic risk scores

11. Genome-Wide Association Study of Apparent Treatment-Resistant Hypertension in the CHARGE Consortium: The CHARGE Pharmacogenetics Working Group

12. Genome-wide meta-analysis of SNP-by9-ACEI/ARB and SNP-by-thiazide diuretic and effect on serum potassium in cohorts of European and African ancestry

13. Genome-wide polygenic score to predict chronic kidney disease across ancestries

15. Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations

16. Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy

22. Key Contextual Factors Involved with Participation in Medical and Genomic Screening and Research for African American and Caucasian Americans: A Qualitative Inquiry American Journal of Community Genetics

23. Polygenic Risk for Type 2 Diabetes in African Americans

24. Polygenic Risk for Type 2 Diabetes in African Americans

25. A methylation risk score for chronic kidney disease: a HyperGEN study

26. Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data

28. Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing

31. A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

32. Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

34. Strong protective effect of theAPOL1p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease

35. Returning integrated genomic risk and clinical recommendations: The eMERGE study

36. Participant-guided development of bilingual genomic educational infographics for Electronic Medical Records and Genomics Phase IV study.

40. Risk factors affecting polygenic score performance across diverse cohorts

49. Hypertension severity, apparent treatment resistant hypertension and hyperuricemia in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study

Catalog

Books, media, physical & digital resources